Ortega-Valle Marta 4

4 · GreenLight Biosciences Holdings, PBC · Filed Feb 4, 2022

Form 4

Period: 2022-02-02

Chief Business Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-02+29,798→ 29,798 total
Exercise: $0.24Exp: 2022-06-08→ Common Stock (29,798 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+105,266→ 105,266 total
Exercise: $0.28Exp: 2023-12-13→ Common Stock (105,266 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+106,098→ 106,098 total
Exercise: $0.35Exp: 2025-07-22→ Common Stock (106,098 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+247,727→ 247,727 total
Exercise: $0.98Exp: 2030-09-24→ Common Stock (247,727 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+259,584→ 259,584 total
Exercise: $0.98Exp: 2030-12-01→ Common Stock (259,584 underlying)

Footnotes (6)

[F1]100% of the shares subject to this option are fully vested and exercisable.
[F2]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
[F3]100% of the shares subject to this option are fully vested and exercisable.
[F4]100% of the shares subject to this option are fully vested and exercisable.
[F5]20% of the shares underlying the option vested or shall vest on September 24, 2021 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 24, 2021.
[F6]25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.

Documents

1 file